CN103018389A - High performance liquid chromatography method and application thereof - Google Patents

High performance liquid chromatography method and application thereof Download PDF

Info

Publication number
CN103018389A
CN103018389A CN2011102858051A CN201110285805A CN103018389A CN 103018389 A CN103018389 A CN 103018389A CN 2011102858051 A CN2011102858051 A CN 2011102858051A CN 201110285805 A CN201110285805 A CN 201110285805A CN 103018389 A CN103018389 A CN 103018389A
Authority
CN
China
Prior art keywords
liquid chromatography
performance liquid
high performance
analytical approach
androstenedione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011102858051A
Other languages
Chinese (zh)
Other versions
CN103018389B (en
Inventor
岳崇斌
岳光
赵德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHONGQING DAXIN PHARMACEUTICAL CO LTD
New Founder Holdings Development Co ltd
Peking University Medical Management Co ltd
Peking University Founder Group Co Ltd
PKU Healthcare Industry Group
Original Assignee
CHONGQING DAXIN PHARMACEUTICALS Co Ltd OF PKU INTERNATIONAL HEALTHCARE GROUP
Peking University Founder Group Co Ltd
PKU International Healthcare Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHONGQING DAXIN PHARMACEUTICALS Co Ltd OF PKU INTERNATIONAL HEALTHCARE GROUP, Peking University Founder Group Co Ltd, PKU International Healthcare Group Co Ltd filed Critical CHONGQING DAXIN PHARMACEUTICALS Co Ltd OF PKU INTERNATIONAL HEALTHCARE GROUP
Priority to CN201110285805.1A priority Critical patent/CN103018389B/en
Publication of CN103018389A publication Critical patent/CN103018389A/en
Application granted granted Critical
Publication of CN103018389B publication Critical patent/CN103018389B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention provides a high performance liquid chromatography method and application thereof. The method is characterized by carrying out component analysis of a steroid compound-containing mixture by a high performance liquid chromatography, wherein the high performance liquid chromatography adopts reversed high performance liquid chromatography and gradient elution, and mobile phases adopted by the gradient elution respectively are water and acetonitrile having the content of 95%. Through the high performance liquid chromatography method, the steroid compound-containing mixture (such as a mixture containing androstenedione and/or phytosterol) can be simultaneously analyzed. The high performance liquid chromatography method eliminates the interference factors, greatly shortens analysis time, has simple, reliable and accurate processes, and solves the existing problems of many operation steps, long analysis time and many interference factors. Therefore, the high performance liquid chromatography method provides an effective approach for steroid drug research and production process industrial production management.

Description

HPLC analytical method and application thereof
Technical field
The present invention relates to the synthetic field of microorganism of steroid drugs, in particular to a kind of HPLC analytical method and the application in plant sterol microbial conversion production androstenedione thereof.
Background technology
In recent years steroid drugs production sustainable growth, and traditional steroid drugs production mainly is to extract diosgenin to form by chemosynthesis from the plants such as wild Chinese crude drug " earthworm ", its technique is very complicated, raw materials used in short supply, cost is very high, and contaminated environment, therefore, rise rapidly take plant sterol as the processing industry of raw material synthesizing steroid medicine, and grow up with surprising rapidity.Plant sterol has become the synthetic primary raw material of steroid drugs at present.This fundamentally changes, and traditional chemical synthesizing steroid medicine step is many, the deficiency of the aspects such as yield is low, price; also take full advantage of resources advantage; break away from the starting material source because of the restriction of the natural causes such as season, region to producing, be conducive to protect national resource and ecology.
Androstenedione (AD) is the synthetic key intermediates of many steroid drugs, is one of important raw and processed materials of producing the steroid hormone medicine.As precursor, it can continue more than the 20 kind of steroid hormone medicines such as synthetic all corticoids, estrogen, androgen, protein anabolic hormone.The method of producing at present androstenedione is to utilize specific microbial strains, in water/organic solvent two-phase fermentation system, with the side chain selective ablation of plant sterol, thereby changes into androstenedione.The structural formula of androstenedione is:
Figure BDA0000093834110000011
In the process of utilizing microbe transformation method production androstenedione, employed raw material is from the concise leftover bits and pieces of vegetable oil, the plant sterol that extracts in the deodorization distillate, it is brassicasterol (Brassicasterol), campesterol (Campesterol), stigmasterol (Stigmasterol), the cupreol (potpourri of β-Sitosterol), the structure of these 4 kinds of monomer sterols is closely similar, only there are differences in individual groups, structural formula separately is as follows:
The campesterol cupreol
Campesterol β-Sitosterol
Figure BDA0000093834110000022
The stigmasterol brassicasterol
Stigmasterol Brassicasterol
This structural roughly similarity has brought certain difficulty for follow-up characterization processes, utilize traditional detection method to be difficult to it is separated, thereby can't learn that microorganism especially has a liking for any plant sterol during the fermentation, select to make troubles for later raw material.Simultaneously during the fermentation, not only synthesized androstenedione, and had many accessory substances to generate, the generation of these accessory substances may affect the Accurate Determining of androstenedione, makes troubles for the production of enterprise.Therefore, be necessary to seek one or more methods, so that can Accurate Determining plant sterol and androstenedione.
The method of measuring at present plant sterol in the prior art has:
1. the classic method gravimetric method namely adopts digitonin to react with sterol under certain condition, and generation precipitates the drying weighing and records sterol content.The method operation steps is many, analysis time is long, disturbing factor is more;
2.TLC thin layer chromatography, and can only carry out "ball-park" estimate with the TLC thin layer chromatography board, because the microbial conversion product structure of plant sterol approaches, use thin layer chromatography sensitivity low, do not meet the advance of production target;
3. high performance liquid chromatography detection method, adopt the UV detecting device, and with methyl alcohol as mobile phase, the detection wavelength is 205nm (absorbing wavelength), and its wavelength is short to be disturbed greatly, is subject to the impact of mobile phase, sample treatment, bring certain difficulty to analysis, and the sample determination time is longer, and selectivity is relatively relatively poor, is difficult to the structural similarity product is detected;
4. vapor-phase chromatography, sample need esterified 30 minutes, also need extract, the operation steps such as evaporate to dryness, the disposal route time is long, disturbing factor is many.
Summary of the invention
For solving above-mentioned problems of the prior art, the invention provides a kind of HPLC analytical method and application thereof.
Particularly, the invention provides:
(1) a kind of HPLC analytical method, described analytical approach comprises: the potpourri that contains steroid compound is carried out constituent analysis with high performance liquid chromatography;
Wherein, described high performance liquid chromatography adopts reversed-phase high-performance liquid chromatography, and adopts gradient elution, and the mobile phase of wherein said gradient elution is respectively water and 95% acetonitrile.
(2) analytical approach according to claim 1, wherein, described steroid compound comprises: androstenedione and/or plant sterol; Preferably, described plant sterol comprises brassicasterol, campesterol, stigmasterol and/or cupreol.
(3) according to (1) described analytical approach, wherein, the detecting device that described high performance liquid chromatography adopts is diode array detector (DAD).
(4) according to (3) described analytical approach, wherein, the detection wavelength that described high performance liquid chromatography adopts is 210nm.
(5) according to (1) described analytical approach, wherein, the condition of described gradient elution is set as by the time segmentation:
0 to 6 minute, water was that 10-15 parts by volume, 95% acetonitrile are the 90-85 parts by volume;
Greater than 6 minutes to 30 minutes, water was that 0 parts by volume, 95% acetonitrile are 100 parts by volume;
Greater than 30 minutes to 35 minutes, water was that 10-15 parts by volume, 95% acetonitrile are the 90-85 parts by volume.
(6) according to (5) described analytical approach, wherein, the time of described gradient elution and the program of flow velocity are as shown in the table:
Figure BDA0000093834110000041
(7) according to (5) described analytical approach, wherein, described mobile phase flows in A pump and B pump respectively, and the condition of described gradient elution is:
Figure BDA0000093834110000042
Wherein, be water in the described A pump, be 95% acetonitrile in the described B pump.
(8) according to (1) described analytical approach, wherein, described high performance liquid chromatography adopts the octadecylsilane chemically bonded silica post, and described octadecylsilane chemically bonded silica post is 150mm * 4.6mm, and column temperature is 30 ℃, and sample size is 3-20 μ l.
(9) according to each described analytical approach in (1)-(8), described analytical approach further comprises to be measured the content of each composition in the described potpourri, and described mensuration comprises:
1) prepares respectively the standard solution of androstenedione, brassicasterol, campesterol, stigmasterol and the cupreol of variable concentrations, adopt described high performance liquid chromatography to measure respectively the peak area of described each standard solution, and draw respectively peak area-concentration standard curve for androstenedione, brassicasterol, campesterol, stigmasterol and cupreol;
2) described potpourri is mixed with sample solution, adopts the peak area of the described sample solution of described high effective liquid chromatography for measuring; And
3) calculated the concentration of each composition in the described sample solution by described typical curve, and calculate thus the content of each composition in the described potpourri.
(10) application of each described analytical approach in plant sterol microbial conversion production androstenedione in above-mentioned (1)-(9), this application comprises: adopt described analytical approach that the fermentation liquor in this microbial conversion process is carried out constituent analysis.
(11) according to (10) described application, this application also comprises: according to the result of described constituent analysis, determine the concentration of brassicasterol, campesterol, stigmasterol and cupreol in the described fermentation liquor, and thus the plant sterol that adopts in the described microbial conversion is selected.
(12) according to (10) described application, this applications also comprises: according to the result of described constituent analysis, determine the concentration of androstenedione in the described fermentation liquor and/or plant sterol, and determine thus the process of production and/or the terminal point of production.
Of the present invention compared with prior art having the following advantages and good effect:
The invention discloses a kind of HPLC analytical method, the middle control analysis that it can be used for the steroid drugs production run and produces terminal point, can be simultaneously to containing the potpourri of steroid compound, as contain androstenedione, brassicasterol, campesterol, the potpourri of stigmasterol and/or cupreol, analyze, eliminated disturbing factor, greatly shortened analysis time, simple to operate, reliably, accurately, it is many to have changed operation steps in the past, analysis time is long, therefore the factors such as disturbing factor is more provide the effective means that steroid drugs research work and production run suitability for industrialized production are managed.
Description of drawings
Fig. 1 is the chromatogram of blank (acetonitrile);
Fig. 2 is the chromatogram of standard solution;
Fig. 3 is the canonical plotting of androstenedione (AD);
Fig. 4 is the canonical plotting of brassicasterol;
Fig. 5 is the canonical plotting of campesterol;
Fig. 6 is the canonical plotting of stigmasterol;
Fig. 7 is the canonical plotting of cupreol;
Fig. 8 transforms the mensuration figure of the 130h tunning of production phase for fermentation;
Fig. 9 is the mensuration figure of the extraction separation and purification crude product of androstenedione (AD).
Embodiment
Below the invention will be further described by the description of embodiment and with reference to accompanying drawing, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The purpose of this invention is to provide a kind of efficient, simple to operate, reliably, high performance liquid chromatography middle control analysis method accurately.
In a kind of embodiment of analytical approach of the present invention, the potpourri that the contains steroid compound potpourri of androstenedione and/or plant sterol (as contain) is carried out constituent analysis with high performance liquid chromatography, high performance liquid chromatography is reversed-phase high-performance liquid chromatography, and the employing gradient elution, high-efficient liquid phase chromatogram condition can be:
Chromatographic column: octadecylsilane chemically bonded silica post, i.e. C 18Post, 150 * 4.6mm (I.D);
Mobile phase: A: water; B:95% (v/v) acetonitrile.
The condition of gradient elution can be set as by the time segmentation:
0 to 6 minute, water was that 10-15 parts by volume, 95% acetonitrile are the 90-85 parts by volume;
Greater than 6 minutes to 30 minutes, water was that 0 parts by volume, 95% acetonitrile are 100 parts by volume;
Greater than 30 minutes to 35 minutes, water was that 10-15 parts by volume, 95% acetonitrile are the 90-85 parts by volume.
For example:
0-6 minute, water was that 10-15 parts by volume, 95% acetonitrile are the 90-85 parts by volume;
6.01-30.0 minute, water is that 0 parts by volume, 95% acetonitrile are 100 parts by volume;
30.01-35.0 minute, water is that 10-15 parts by volume, 95% acetonitrile are the 90-85 parts by volume.
The gradient elution program is carried out wash-out shown in the further preferred employing table 1.
Table 1 gradient elution program
Figure BDA0000093834110000071
Other condition can for:
Column temperature: 30 ℃;
Wavelength: 210nm (DAD detecting device);
Sample size: 3-20 μ l (being preferably 10 μ l).
Reagent and medicine:
Androstenedione, reference substance (content 〉=99%);
Brassicasterol, reference substance (content 〉=98%);
Campesterol, reference substance (content 〉=98%);
Stigmasterol, reference substance (content 〉=96%);
Cupreol, reference substance (content 〉=98%);
Acetonitrile (HPLC level);
Mobile phase and solution with water are redistilled water in the test.
Prepare respectively the reference substance solution of androstenedione, brassicasterol, campesterol, stigmasterol and the cupreol of variable concentrations, adopt above-mentioned high performance liquid chromatography to measure respectively the peak area of described each reference substance solution, and draw respectively peak area-concentration standard curve for androstenedione, brassicasterol, campesterol, stigmasterol and cupreol; Prepare sample solution, adopt the peak area of above-mentioned high effective liquid chromatography for measuring sample solution; Calculated the concentration of each composition in the sample solution by typical curve.
Analytical approach of the present invention can be produced in the androstenedione in the plant sterol microbial conversion and be used, and can carry out collected specimens to the fermentation liquor of stages in this microbial conversion process, then adopts analytical approach of the present invention to carry out constituent analysis.The embodiment that the present invention uses can be: according to the result of the constituent analysis of the sample of fermentation liquor, determine the concentration of brassicasterol in the fermentation liquor, campesterol, stigmasterol and cupreol, and thus the plant sterol that adopts in the microbial conversion is selected.Such as, other plant sterol of the consumption rate of stigmasterol is many, then can determine this microbial strains preference stigmasterol, can the fermenting and producing of this microbial strains be optimized so thus, for example, can mainly add stigmasterol in the fermentation next time.Another embodiment that the present invention uses can be: according to the result of the constituent analysis of the sample of fermentation liquor, determine the concentration of androstenedione in the fermentation liquor and/or plant sterol, and determine thus the process of producing and/or the terminal point of production.Such as, the concentration that the concentration of androstenedione reaches peak value or certain plant sterols in certain stage sample reaches minimum, can determine then that produce this moment to finish.
Mode by the following examples further explains and describes content of the present invention, but these embodiment are not to be construed as limiting the scope of the invention.
Experimental apparatus in following examples and chromatographic condition are:
Agilent 1100 type high performance liquid chromatographs, Agilent 1100 type DAD detecting devices, Agilent 1100 type column ovens, the stratographic analysis record is finished by the Agilent workstation.
Experimental apparatus and chromatographic condition:
Chromatographic column: C 18Post, 150 * 4.6mm (ID);
Mobile phase: A: water; The B:95% acetonitrile;
Table 2 gradient elution program
Figure BDA0000093834110000091
Column temperature: 30 ℃;
Wavelength: 210nm (DAD detecting device);
Sample size: 10 μ l.
In following examples, androstenedione can be available from the special reagent of Chengdu bass company limited; Brassicasterol can be available from Supeleo company; Campesterol can be available from Sigma company; Stigmasterol can be available from Sigma company; Cupreol can be available from Sigma company; Acetonitrile can be available from Chemical Reagent Co., Ltd., Sinopharm Group.
Embodiment 1: the selection of chromatographic condition
1.1 the selection of mobile phase
Why the present invention selects acetonitrile and water is mobile phase, is the consideration for following factor: eliminate the disturbing factor of mobile phase to detecting when measuring, to improve reliability, accuracy; Improve each peak-to-peak degree of separation; And use gradient elution to make androstenedione and front and back impurity reach effective separation, make between brassicasterol, campesterol, stigmasterol, cupreol to reach effective separation; See blank sheet 1, hybrid standard Fig. 2 (peak sequence is androstenedione (AD), brassicasterol, campesterol, stigmasterol, cupreol).
1.2 detect the selection of wavelength
In acetonitrile, carry out continuous sweep with the DAD detecting device at 190-400nm by sample dissolution, androstenedione (AD) has absorption maximum at the 240nm place as can be known; Brassicasterol, campesterol, stigmasterol, cupreol have absorption maximum at the 210nm place; Take into account each component sensitivity, selecting to detect wavelength is 210nm.
1.3 sample concentration
In order to take into account the mensuration of product androstenedione (AD) and reaction substrate brassicasterol in the sample, campesterol, stigmasterol, cupreol content, take 32.0,204.0,203.0,205.0,203.0 μ g/ml concentration as 100%, by blank application of sample recovery test preparation 80%, 120% concentration, measure its experimental accuracy, see Table 3.
The recovery result of table 3 androstenedione (AD) and brassicasterol, campesterol, stigmasterol, cupreol
Figure BDA0000093834110000101
1.4 sample solution preparation
Precision takes by weighing the about 0.02g of test sample and dissolves with acetonitrile in the 25ml volumetric flask, and ultrasonic 7 minutes, constant volume, shake up, organic 0.22 μ m membrane filtration and get final product is need testing solution.
Precision takes by weighing reference substance androstenedione (AD), brassicasterol, campesterol, stigmasterol, cupreol respectively, and respectively at dissolving with an amount of acetonitrile in each 25ml volumetric flask, ultrasonic 7 minutes, constant volume was standard reserving solution.
Hybrid standard liquid:
It is an amount of that precision pipettes each standard reserving solution respectively, in same 25ml volumetric flask with the acetonitrile constant volume, shake up, with organic 0.22 μ m membrane filtration and get final product, be hybrid standard liquid; Make and be about respectively androstenedione (AD) (32.0 μ g/ml), brassicasterol (204.0 μ g/ml), campesterol (203.0 μ g/ml), stigmasterol (205.0 μ g/ml), cupreol (203.0 μ g/ml).
Embodiment 2
The making of typical curve
Be about respectively 6.22-52.65 μ g/ml, 28.0-405.0 μ g/ml, 27.9-402.6 μ g/ml, 28.22-407.2 μ g/ml and 27.93-402.9 μ g/ml in androstenedione (AD), brassicasterol, campesterol, stigmasterol and cupreol concentration, sample introduction 10 μ l, with peak area A concentration μ g/ml is mapped, see Fig. 3, Fig. 4, Fig. 5, Fig. 6, Fig. 7, regression equation is:
Androstenedione (AD) y=6.9463x+0.12r=0.99998;
Brassicasterol y=1.8587x+1.1906r=0.99986;
Campesterol y=2.4101x+0.7561r=0.99993;
Stigmasterol y=1.0758x+1.9945r=0.99995;
Cupreol y=1.0767x+1.9858r=0.99993;
Embodiment 3
The mensuration of standard weight renaturation
Hybrid standard liquid:
It is an amount of that precision pipettes each standard reserving solution respectively, in same 25ml volumetric flask with the acetonitrile constant volume, shake up, with organic 0.22 μ m membrane filtration and get final product, be hybrid standard liquid; Make and be about respectively androstenedione (AD) (32.0 μ g/ml), brassicasterol (204.0 μ g/ml), campesterol (203.0 μ g/ml), stigmasterol (205.0 μ g/ml), cupreol (203.0 μ g/ml), sample introduction 10 μ l, advance continuously 6 pins, RSD% sees Table 4 with calculated by peak area.
Table 4 replica test is table as a result
Figure BDA0000093834110000131
Embodiment 4
Fermentation transforms the application in producing
The fermentation culture (by weight) that fermentation transforms the production phase comprises: sugar 10.0%, plant sterol 5.0%, vegetable oil 20%, NH 4NO 30.5%, pH value 8.5-8.8; To wherein adding mycobacterium, rotating speed 250-280rpm/min is to plant sterol degraded generation androstenedione; Growth cycle was at 126-138 hour, and timing sampling detects; The operation break-down sampling of extraction separation and purification stage is detected.
Test sample 1: fermentation transforms 130 hours tunnings of production phase
Precision takes by weighing test sample 1 about 0.5g and dissolves with acetonitrile in the 50ml volumetric flask, and ultrasonic 7 minutes, constant volume, shake up, organic 0.22 μ m membrane filtration and get final product is need testing solution, sample size: 10 μ l.The result as shown in Figure 8.Can find out that wherein plant sterol is consumed substantially, and changes into androstenedione.
Test sample 2:(androstenedione (AD)) extraction separation and purification crude product
Precision takes by weighing test sample 2 about 0.02g and dissolves with acetonitrile in the 50ml volumetric flask, and ultrasonic 7 minutes, constant volume, shake up, organic 0.22 μ m membrane filtration and get final product is need testing solution, sample size: 10 μ l.The result as shown in Figure 9.Wherein can find out, separate obtaining purer androstenedione (AD.
This shows, can adopt HPLC analytical method of the present invention that fermentation conversion production and separation and purification process are controlled.

Claims (12)

1. HPLC analytical method, described analytical approach comprises: the potpourri that contains steroid compound is carried out constituent analysis with high performance liquid chromatography;
Wherein, described high performance liquid chromatography adopts reversed-phase high-performance liquid chromatography, and adopts gradient elution, and the mobile phase of wherein said gradient elution is respectively water and 95% acetonitrile.
2. analytical approach according to claim 1, wherein, described steroid compound comprises: androstenedione and/or plant sterol; Preferably, described plant sterol comprises brassicasterol, campesterol, stigmasterol and/or cupreol.
3. analytical approach according to claim 1, wherein, the detecting device that described high performance liquid chromatography adopts is diode array detector.
4. analytical approach according to claim 3, wherein, the detection wavelength that described high performance liquid chromatography adopts is 210nm.
5. analytical approach according to claim 1, wherein, the condition of described gradient elution is set as by the time segmentation:
0 to 6 minute, water was that 10-15 parts by volume, 95% acetonitrile are the 90-85 parts by volume;
Greater than 6 minutes to 30 minutes, water was that 0 parts by volume, 95% acetonitrile are 100 parts by volume;
Greater than 30 minutes to 35 minutes, water was that 10-15 parts by volume, 95% acetonitrile are the 90-85 parts by volume.
6. analytical approach according to claim 5, wherein, the time of described gradient elution and the program of flow velocity are as shown in the table:
Figure FDA0000093834100000011
Figure FDA0000093834100000021
7. analytical approach according to claim 5, wherein, described mobile phase flows in A pump and B pump respectively, and the condition of described gradient elution is:
Figure FDA0000093834100000022
Wherein, be water in the described A pump, be 95% acetonitrile in the described B pump.
8. analytical approach according to claim 1, wherein, described high performance liquid chromatography adopts the octadecylsilane chemically bonded silica post, and described octadecylsilane chemically bonded silica post is 150mm * 4.6mm, and column temperature is 30 ℃, and sample size is 3-20 μ l.
9. each described analytical approach according to claim 1-8, described analytical approach further comprise to be measured the content of each composition in the described potpourri, and described mensuration comprises:
1) prepares respectively the standard solution of androstenedione, brassicasterol, campesterol, stigmasterol and the cupreol of variable concentrations, adopt described high performance liquid chromatography to measure respectively the peak area of described each standard solution, and draw respectively peak area-concentration standard curve for androstenedione, brassicasterol, campesterol, stigmasterol and cupreol;
2) described potpourri is mixed with sample solution, adopts the peak area of the described sample solution of described high effective liquid chromatography for measuring; And
3) calculated the concentration of each composition in the described sample solution by described typical curve, and calculate thus the content of each composition in the described potpourri.
10. the application of each described analytical approach in plant sterol microbial conversion production androstenedione among the claim 1-9, this application comprises: adopt described analytical approach that the fermentation liquor in this microbial conversion process is carried out constituent analysis.
11. application according to claim 10, this application also comprises: according to the result of described constituent analysis, determine the concentration of brassicasterol, campesterol, stigmasterol and cupreol in the described fermentation liquor, and thus the plant sterol that adopts in the described microbial conversion is selected.
12. application according to claim 10, this application also comprises: according to the result of described constituent analysis, determine the concentration of androstenedione in the described fermentation liquor and/or plant sterol, and determine thus the process of producing and/or the terminal point of production.
CN201110285805.1A 2011-09-23 2011-09-23 High performance liquid chromatography method and application thereof Expired - Fee Related CN103018389B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110285805.1A CN103018389B (en) 2011-09-23 2011-09-23 High performance liquid chromatography method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110285805.1A CN103018389B (en) 2011-09-23 2011-09-23 High performance liquid chromatography method and application thereof

Publications (2)

Publication Number Publication Date
CN103018389A true CN103018389A (en) 2013-04-03
CN103018389B CN103018389B (en) 2015-01-07

Family

ID=47967228

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110285805.1A Expired - Fee Related CN103018389B (en) 2011-09-23 2011-09-23 High performance liquid chromatography method and application thereof

Country Status (1)

Country Link
CN (1) CN103018389B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103232513A (en) * 2013-05-09 2013-08-07 南京中医药大学 Method for preparing tirucallol
CN107782828A (en) * 2017-12-12 2018-03-09 江南大学 A kind of method by high efficiency liquid chromatography for separating and determining campesterol, stigmasterol and Sitosterolum
CN115015424A (en) * 2022-06-10 2022-09-06 完美(广东)日用品有限公司 High performance liquid chromatography fingerprint construction method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001095597A (en) * 1999-07-27 2001-04-10 Shiseido Co Ltd Detection of steroid 5 alpha-reductase-inhibiting activity
CN1560626A (en) * 2004-03-02 2005-01-05 华南理工大学 Separation analyzing method for lipophilicity extraction in agricultural waste
CN1639354A (en) * 2002-02-01 2005-07-13 阿克佐诺贝尔公司 Process for fermentation of phytosterols to androstadienedione
WO2010123243A2 (en) * 2009-04-23 2010-10-28 영남대학교 산학협력단 Composition containing a testis extract for treating or preventing diseases
CN101963604A (en) * 2010-10-29 2011-02-02 川渝中烟工业公司 Method for measuring sterol in tobaccos

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001095597A (en) * 1999-07-27 2001-04-10 Shiseido Co Ltd Detection of steroid 5 alpha-reductase-inhibiting activity
CN1639354A (en) * 2002-02-01 2005-07-13 阿克佐诺贝尔公司 Process for fermentation of phytosterols to androstadienedione
CN1560626A (en) * 2004-03-02 2005-01-05 华南理工大学 Separation analyzing method for lipophilicity extraction in agricultural waste
WO2010123243A2 (en) * 2009-04-23 2010-10-28 영남대학교 산학협력단 Composition containing a testis extract for treating or preventing diseases
CN101963604A (en) * 2010-10-29 2011-02-02 川渝中烟工业公司 Method for measuring sterol in tobaccos

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEN-LANG HUANG ET AL: "Production of androstenones from phytosterol by mutants of Mycobacterium sp.", 《ENZYME AND MICROBIAL TECHNOLOGY》 *
MARINA V DONOVA ET AL: "Microbial conversion of sterol-containing soybean oil production waste", 《JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY》 *
杨虹 等: "食用油中植物甾醇测定方法的优化及含量分析", 《中国粮油学报》 *
沈微 等: "高效液相色谱_质谱联用法分析微生物降解植物甾醇为雄甾烯酮", 《微生物学通报》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103232513A (en) * 2013-05-09 2013-08-07 南京中医药大学 Method for preparing tirucallol
CN103232513B (en) * 2013-05-09 2015-06-10 南京中医药大学 Method for preparing tirucallol
CN107782828A (en) * 2017-12-12 2018-03-09 江南大学 A kind of method by high efficiency liquid chromatography for separating and determining campesterol, stigmasterol and Sitosterolum
CN115015424A (en) * 2022-06-10 2022-09-06 完美(广东)日用品有限公司 High performance liquid chromatography fingerprint construction method and application thereof

Also Published As

Publication number Publication date
CN103018389B (en) 2015-01-07

Similar Documents

Publication Publication Date Title
CN101963604B (en) Method for measuring sterol in tobaccos
CN101762647B (en) Method for measuring 2-furfural in beer by using high performance liquid chromatography
CN108707133B (en) Lignans compound, and method and application for extracting and separating lignans compound from eagle tea
CN104280504A (en) Capillary column gas chromatography method for simultaneously determining contents of water and nicotine in main stream smoke of cigarette
CN102735768A (en) Process for jointly detecting estrogens and their associations in livestock and poultry excrements
Gao et al. Directly suspended droplet microextraction combined with single drop back-extraction as a new approach for sample preparation compatible with capillary electrophoresis
Xin et al. Rapid purification of diastereoisomers from Piper kadsura using supercritical fluid chromatography with chiral stationary phases
CN103018389B (en) High performance liquid chromatography method and application thereof
CN104513286A (en) Method for separating and purifying fidaxomicin
CN103852531B (en) Method for detecting malto-oligosaccharide in beer through HPLC-ELSD (High-Performance Liquid Chromatography-Evaporative Light Scattering Detector)
Wang et al. A one-step method for the simultaneous determination of five wood monosaccharides and the corresponding aldonic acids in fermentation broth using high-performance anion-exchange chromatography coupled with a pulsed amperometric detector
CN103267820B (en) Method for simultaneously detecting multiple estrogens in sludge
CN104502477B (en) Organic analytical approach in a kind of trichloroacetaldehyde Waste Sulfuric Acid
CN102321135B (en) Method for separating and purifying cordycepin by utilizing high-speed counter-current chromatography
CN104155375B (en) The method of amino benzenes compounds in synchronous derivative ultrasonic emulsification micro-extraction gas chromatography determination environmental water sample
CN103308642B (en) High performance liquid chromatography-flight time mass spectrum combination method for simultaneously and rapidly screening and identifying antihistamine medicines in water samples
CN107290444A (en) The method for detecting neopterin and biopterin in human urine
Zhou et al. Development and validation of a reversed‐phase HPLC method for quantitative determination of ginsenosides Rb1, Rd, F2, and compound K during the process of biotransformation of ginsenoside Rb1
CN105628631B (en) A kind of rapid detection method of hydrocortisone Biocatalytic Conversion rate
CN102455331A (en) Method for rapidly analyzing microbial community structures of strong fragrance liquor cellar
CN103983729B (en) A kind of gas chromatography-mass spectrum detects the method for acyl homoserine lactones in the soil liquid
CN103512975A (en) Method for analyzing contents of effective substances in Cordyceps martialis fruiting body and residue by HPLC
CN113583077B (en) Process for preparing sterols
CN102382155A (en) Rice syrup extractive and application thereof
CN103926368B (en) Method for extracting biotin from corn steep liquor and thin layer chromatography (TLC) scanning detection method of biotin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 100871, Beijing, Haidian District Cheng Fu Road 298, founder building, 9 floor

Patentee after: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd.

Patentee after: CHONGQING DAXIN PHARMACEUTICAL Co.,Ltd.

Patentee after: PKU HEALTHCARE INDUSTRY Group

Address before: 100871, Beijing, Haidian District, Cheng Fu Road, No. 298, Zhongguancun Fangzheng building, 5 floor

Patentee before: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd.

Patentee before: Peking University International Hospital Group Chongqing Daxin Pharmaceutical Co.,Ltd.

Patentee before: Pku Healthcare Industry Group Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20221021

Address after: 3007, Hengqin international financial center building, No. 58, Huajin street, Hengqin new area, Zhuhai, Guangdong 519031

Patentee after: New founder holdings development Co.,Ltd.

Patentee after: CHONGQING DAXIN PHARMACEUTICAL Co.,Ltd.

Patentee after: Peking University Medical Management Co.,Ltd.

Address before: 100871, Beijing, Haidian District Cheng Fu Road 298, founder building, 9 floor

Patentee before: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd.

Patentee before: CHONGQING DAXIN PHARMACEUTICAL Co.,Ltd.

Patentee before: PKU HEALTHCARE INDUSTRY Group

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150107